Palvella Therapeutics, Inc.Palvella Therapeutics, Inc.Palvella Therapeutics, Inc.

Palvella Therapeutics, Inc.

No trades
See on Supercharts

Price target

34.000.000.00%
The 2 analysts offering 1 year price forecasts for PVLA have a max estimate of — and a min estimate of —.

Analyst rating

Based on 2 analysts giving stock ratings to PVLA in the past 3 months.

EPS

Reported
Estimate
Reported
Estimate
Surprise

Revenue

Reported
Estimate
Reported
Estimate
Surprise
Be warned

Frequently Asked Questions


PVLA EPS for the last quarter is −1.69 USD despite the estimation of −4.00 USD. In the next quarter EPS is expected to reach −0.55 USD. Track more of Palvella Therapeutics, Inc. financials and stay on top of what is up with the company.
In the next quarter Palvella Therapeutics, Inc. revenue is expected to reach 0.00 USD. Check out Palvella Therapeutics, Inc. revenue and earnings and make informed decisions.
According to analysts, PVLA price target is 34.00 USD with a max estimate of 38.00 USD and a min estimate of 30.00 USD. Check if this forecast comes true in a year, meanwhile watch Palvella Therapeutics, Inc. stock price chart and keep track of the current situation with PVLA news and stock market news.